Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications: An Adaptive Implementation Study

NCT05166382 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05166382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05166382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications: An Adaptive Implementation Study
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
January 1, 2024
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, type 2 diabetes